Multiple myeloma
Multiple myeloma is a type of cancer that affects plasma cells, which are a type of white blood cell that produces antibodies. In multiple myeloma, the body produces abnormal plasma cells that can accumulate in the bone marrow, leading to symptoms such as bone pain, anemia, and infections.
Treatment options for multiple myeloma depend on the stage of the disease, and one effective treatment option is bone marrow transplantation (BMT), also known as hematopoietic stem cell transplantation (HSCT).
BMT involves replacing a patient's diseased bone marrow with healthy bone marrow stem cells from a donor. The new stem cells will produce healthy plasma cells, which can help to fight the cancer. In multiple myeloma, BMT is used to replace the patient's abnormal plasma cells with healthy ones.
BMT is often used in combination with chemotherapy and/or radiation therapy to help kill the remaining cancer cells and prepare the patient for the transplant.
BMT can be a lifesaving treatment for patients with multiple myeloma, but it is a complex and potentially risky procedure.
One of the biggest challenges of BMT is finding a suitable donor for the patient. A donor must have a similar tissue type as the patient to prevent rejection of the transplant.
Patients who do not have a matched donor can sometimes receive a transplant from a family member who is a partial match or from an unrelated donor through a registry of bone marrow donors.
In summary, BMT is a treatment option for patients with multiple myeloma, where it can replace the patient's abnormal plasma cells with healthy ones.
BMT is a complex and potentially risky procedure that requires careful matching of donors and recipients. However, for some patients with multiple myeloma, BMT can be a lifesaving treatment option.
Do you want to be our solution partner?
